Early Phase 1 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with endometrial cancer (cancer of the lining of the uterus)
- People who are scheduled to have surgery for endometrial cancer
- People who are able to understand what the study involves and agree to follow its rules and attend required appointments
- People who are willing to stop taking folate or folic acid supplements at least 48 hours before receiving the study drug
- People who have signed and dated a consent form agreeing to take part
Who may not be able to join:
- People who are pregnant or who have a positive pregnancy test
- People who have a medical condition that the study doctor believes could put them at risk during the trial (confirm with trial site)
- People who have previously had a severe allergic reaction (anaphylaxis) to products containing indocyanine green (a dye used in medical imaging)
- People who have a known allergy to any ingredient in CYTALUX (the study drug)
- People who have psychological, family, social, or location-related circumstances that may make it difficult to follow the study schedule or attend follow-up visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 215-615-6770
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.